ArticleCells2026
Developmental Changes in the Protein Expression Levels and Localization of the Vesicular Zinc Transporter (ZnT3) in the Mouse Central Auditory System.
Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Vesicular (synaptic) zinc is a neuromodulator that fine-tunes synaptic transmission and sensory processing across many brain areas, including the brainstem, hippocampus, amygdala, and neocortex. Throughout the central auditory system, synaptic zinc plays a crucial role in modulating neurotransmission as well as baseline and adaptive sound processing. However, the developmental changes in the protein expression levels and localization of the vesicular zinc transporter (ZnT3), which loads synaptic zinc into presynaptic vesicles, remain unknown-due in part to the lack of robust ZnT3 antibodies. To address this question, we used the recently developed and validated ZnT3-HA transgenic mouse line, in which the ZnT3 protein contains a C-terminal HA epitope tag. We performed immunohistochemical staining and confocal microscopy in the central auditory system across development to localize and quantify changes in ZnT3 expression and explore potential colocalization of ZnT3 with the vesicular glutamate and GABA transporters VGLUT1 and VGAT, respectively. We found that ZnT3 expression increased significantly between P7 and P14 in both the dorsal cochlear nucleus (DCN) and the auditory cortex (AC), reaching a stable overall expression level and layer distribution by P21. Both in the DCN and AC, ZnT3 was mainly colocalized with VGLUT1. We did not find any significant levels of ZnT3 expression in either the IC or the auditory thalamus. Together, these results highlight major developmental changes in zinc signaling that may affect synaptic transmission and plasticity, as well as normal and pathological sound processing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.